TABLE 1.

Relationships between serum FABP4 and FLI.

Group	All		Diabetes		Obesity		Metabolic syndrome
	ρ	P	ρ	P	ρ	P	ρ	P
Unadjusted	0.387	<0.001	0.444	<0.001	0.392	<0.001	0.300	<0.001
Adjusted*	0.318	<0.001	0.273	<0.001	0.298	<0.001	0.265	<0.001
Adjusted#	0.305	<0.001	0.263	<0.001	0.313	<0.001	0.282	<0.001

Spearman correlations. Significance (P-values) of rho coefficients (ρ) between serum FABP4 and FLI are reported in the whole population (all), diabetes, obesity, and metabolic syndrome patients (unadjusted). P-values corrected by age, gender (*) and by age, gender, glucose, triglycerides, apoA1, apoB100, and AST (^#).